Literature DB >> 25501462

Role of bone scan in the assessment of polymyositis/dermatomyositis.

Young-Sil An1, Chang-Hee Suh, Ju-Yang Jung, Hyoun-Ah Kim.   

Abstract

The aim of this study was to determine the significance of bone scan findings in Korean polymyositis/dermatomyositis (PM/DM) patients. The participants in this study were 26 PM/DM patients who fulfilled the proposed criteria for definite or probable PM/DM. All patients had been examined by bone scan. The results were analyzed visually and quantitatively using the uptake ratios. Correlations between the bone scan parameters of six proximal muscle groups (trapezius, deltoid, biceps, iliopsoas, quadriceps, and gluteus medius and maximus) and clinical parameters (laboratory values and manual muscle test) representing disease activities were assessed. Based on visual analyses of their bone scans, 10 of 14 (71.4 %) patients with active PM/DM had abnormal muscle uptake. Visual grading of the bone scans had a sensitivity and specificity of 74 and 90.9 %, respectively, for the assessment of muscle inflammation. Maximal proximal muscle uptake ratios, as determined on the bone scans, were significantly higher in patients with active PM/DM than in those with inactive disease (median 1.97 vs. 1.02, p = 0.046). Maximal proximal uptake ratios correlated significantly with creatine kinase (r = 0.394, p = 0.046), lactate dehydrogenase (LDH, r = 0.473, p = 0.015), aldolase (r = 0.428, p = 0.029), erythrocyte sedimentation rate (r = 0.412, p = 0.036), C-reactive protein (r = 0.454, p = 0.002), and manual muscle test results (r = -0.399, p = 0.044). Mean proximal muscle uptake ratios correlated significantly with LDH (r = 0.438, p = 0.025) and aldolase (r = 0.572, p = 0.002). Visually assessed proximal muscle uptake grades and maximal proximal muscle uptake ratios as determined by bone scan correlated significantly with the levels of known PM/DM disease activity markers. The findings of this study suggest that bone scan is a useful imaging technique for the evaluation of PM/DM patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25501462     DOI: 10.1007/s10067-014-2837-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  35 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Assessment of skeletal muscle perfusion using contrast-enhanced ultrasonography.

Authors:  Martin Krix; Marc-André Weber; Holger Krakowski-Roosen; Hagen B Huttner; Stefan Delorme; Hans-Ulrich Kauczor; Wulf Hildebrandt
Journal:  J Ultrasound Med       Date:  2005-04       Impact factor: 2.153

3.  Radioisotope scanning in inflammatory muscle disease.

Authors:  M Brown; T R Swift; S M Spies
Journal:  Neurology       Date:  1976-06       Impact factor: 9.910

4.  Non-skeletal accumulation of bone seeking agents: pelvis.

Authors:  C R Goldfarb; F Ongseng; M Kuhn; T Metzger
Journal:  Semin Nucl Med       Date:  1988-04       Impact factor: 4.446

5.  Tc-99m MDP bone scintigraphy of myositis as a manifestation of chronic graft-versus-host disease after non-myeloablative peripheral stem cell transplantation.

Authors:  Maki Mitomo; Chihoko Miyazaki; Masaya Mukai; Yohko Usami; Shunsuke Nagano; Noriko Nakamura; Kohzoh Kubo
Journal:  Ann Nucl Med       Date:  2005-02       Impact factor: 2.668

6.  18F-Fluorodeoxyglucose positron emission tomography for the assessment of myositis: a case series.

Authors:  Nicolo Pipitone; Annibale Versari; Giulio Zuccoli; Gabriele Levrini; Pierluigi Macchioni; Gianluigi Bajocchi; Carlo Salvarani
Journal:  Clin Exp Rheumatol       Date:  2012-08-29       Impact factor: 4.473

7.  Technetium pyrophosphate muscle scans in inflammatory muscle disease.

Authors:  R A Yonker; E M Webster; N L Edwards; P Katz; S Longley; H Petterssen; R S Panush
Journal:  Br J Rheumatol       Date:  1987-08

8.  MRI-guided biopsy in inflammatory myopathy: initial results.

Authors:  A M Pitt; J L Fleckenstein; R G Greenlee; D K Burns; W W Bryan; R Haller
Journal:  Magn Reson Imaging       Date:  1993       Impact factor: 2.546

9.  Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis.

Authors:  Clara Malattia; Maria Beatrice Damasio; Annalisa Madeo; Angela Pistorio; Anna Providenti; Silvia Pederzoli; Stefania Viola; Antonella Buoncompagni; Chiara Mattiuz; Agnese Beltramo; Alessandro Consolaro; Angelo Ravelli; Nicolino Ruperto; Paolo Picco; Gian Michele Magnano; Alberto Martini
Journal:  Ann Rheum Dis       Date:  2013-05-01       Impact factor: 19.103

10.  Localization of technetium-99m diphosphonate in acutely injured muscle. Relationship to muscle calcium deposition.

Authors:  B A Siegel; W K Engel; E C Derrer
Journal:  Neurology       Date:  1977-03       Impact factor: 9.910

View more
  3 in total

1.  Bone Scan in Identification, Assessment of Initial Extent and Response to Therapy in Polymyositis.

Authors:  Malik E Juweid; Noor Mashhadani; Omar M Albtoush; Rahma Doudeen; Ahmad Al-Momani; Mohammed Aloqaily; Akram Al-Ibraheem
Journal:  Asia Ocean J Nucl Med Biol       Date:  2022

2.  Diagnostic role of technitium-99m bone scan in severe COVID-19-associated myositis.

Authors:  Glen Hookey; Qamar Ahmad; Thomas McCune; Jolanta Kowalewska; Barbara Amaker; Nadeem Inayat
Journal:  Radiol Case Rep       Date:  2021-05-14

3.  AST/ALT ratio as a predictor of mortality and exacerbations of PM/DM-ILD in 1 year-a retrospective cohort study with 522 cases.

Authors:  Renjiao Li; Wen-Jun Zhu; Faping Wang; Xiaoju Tang; Fengming Luo
Journal:  Arthritis Res Ther       Date:  2020-09-20       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.